These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 4211754)

  • 21. Physical factors affecting the production of organic solvent-tolerant protease by Pseudomonas aeruginosa strain K.
    Rahman RN; Geok LP; Basri M; Salleh AB
    Bioresour Technol; 2005 Mar; 96(4):429-36. PubMed ID: 15491823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Roles of exoenzymes and exotoxin in the pathogenicity of Pseudomonas aeruginosa and the development of a new vaccine.
    Homma JY
    Jpn J Exp Med; 1980 Jun; 50(3):149-65. PubMed ID: 6776324
    [No Abstract]   [Full Text] [Related]  

  • 23. Extracellular toxins of Pseudomonas aeruginosa. III. Radioimmunoassay for detection of alkaline protease.
    Döring G; Obernesser HJ; Botzenhart K
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):239-47. PubMed ID: 6812321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physical and chemical factors affecting the adherence of Pseudomonas aeruginosa to a rabbit cornea cell line (SIRC) cells.
    Iida T; Katoh M; Matsuo Y
    Hiroshima J Med Sci; 1985 Jun; 34(2):201-7. PubMed ID: 3928533
    [No Abstract]   [Full Text] [Related]  

  • 25. [Statistic comparative evaluation of laboratory tests on the inhibitory effect of gentamicin on Pseudomonas aeruginosa].
    Sandi C
    G Ital Chemioter; 1969; 16(1):426-31. PubMed ID: 4998310
    [No Abstract]   [Full Text] [Related]  

  • 26. Are clinical isolates of Pseudomonas aeruginosa more virulent than hospital environmental isolates in amebal co-culture test?
    Fenner L; Richet H; Raoult D; Papazian L; Martin C; La Scola B
    Crit Care Med; 2006 Mar; 34(3):823-8. PubMed ID: 16505663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Biofilm formation and response to oxidative stress in Pseudomonas aeruginosa and Vibrio cholerae non-O1 depending on culture media].
    Hostacká A; Ciznár I
    Epidemiol Mikrobiol Imunol; 2007 Nov; 56(4):186-90. PubMed ID: 18064800
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recovery of Pseudomonas aeruginosa colonial dissociants on a protease detection medium.
    Janda JM; Sheehan DJ; Bottone EJ
    J Clin Microbiol; 1982 Jan; 15(1):178-80. PubMed ID: 6821204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolites from an Antarctic sponge-associated bacterium, Pseudomonas aeruginosa.
    Jayatilake GS; Thornton MP; Leonard AC; Grimwade JE; Baker BJ
    J Nat Prod; 1996 Mar; 59(3):293-6. PubMed ID: 8882433
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decolorization of azo dyes and simulated dye bath wastewater using acclimatized microbial consortium--biostimulation and halo tolerance.
    Dafale N; Rao NN; Meshram SU; Wate SR
    Bioresour Technol; 2008 May; 99(7):2552-8. PubMed ID: 17566726
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracellular toxins of Pseudomonas aeruginosa. IV. Radioimmunoassay for detection of elastase.
    Obernesser HJ; Döring G
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Jun; 252(2):248-56. PubMed ID: 6812322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Purification and properties of -lactamase of pseudomonas aeruginosa.
    Zyk N; Kalkstein A; Citri N
    Isr J Med Sci; 1972 Dec; 8(12):1906-11. PubMed ID: 4347730
    [No Abstract]   [Full Text] [Related]  

  • 33. Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa.
    Hocquet D; Muller A; Blanc K; Plésiat P; Talon D; Monnet DL; Bertrand X
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1173-5. PubMed ID: 18180356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of immune inhibitor from Pseudomonas aeruginosa of inducible cell-free antibacterial activity in insects.
    Jarosz J
    Cytobios; 1997; 89(357):73-80. PubMed ID: 9363620
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular toxins of Pseudomonas aeruginosa.
    Liu PV
    J Infect Dis; 1974 Nov; 130 Suppl(0):S94-9. PubMed ID: 4370620
    [No Abstract]   [Full Text] [Related]  

  • 36. A method for the detection of gelatinase production by bacteria.
    Pitt TL; Dey D
    J Appl Bacteriol; 1970 Dec; 33(4):687-91. PubMed ID: 4995938
    [No Abstract]   [Full Text] [Related]  

  • 37. The roles of various fractions of Pseudomonas aeruginosa in its pathogenesis. 3. Identity of the lethal toxins produced in vitro and in vivo.
    Liu PV
    J Infect Dis; 1966 Oct; 116(4):481-9. PubMed ID: 4959184
    [No Abstract]   [Full Text] [Related]  

  • 38. A more sensitive plate assay for detection of protease production by Pseudomanas aeruginosa.
    Sokol PA; Ohman DE; Iglewski BH
    J Clin Microbiol; 1979 Apr; 9(4):538-40. PubMed ID: 110831
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular permeability factor of Pseudomonas aeruginosa.
    Kusama H; Suss RH
    Infect Immun; 1972 Mar; 5(3):363-9. PubMed ID: 4629079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of a plasma kinin-inactivating enzyme produced by Pseudomonas aeruginosa.
    Rugstad HE
    Br J Pharmacol Chemother; 1967 Jun; 30(2):425-35. PubMed ID: 4962445
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.